54721
49736
S&P/TSX
15552.06
+67.74
(0.44%)
S&P-CDNX
797.41
-7.55
(-0.94%)
S&P-500
2670.29
+0.15
(0.01%)
NASDAQ
7128.60
-17.52
(-0.25%)
Dow
24448.69
-14.25
(-0.06%)
Dollar
0.77965
+0.00104
(+0.13332%)
Oil
68.98
+0.34
(+0.50%)
Gold
1329.20
+5.20
(+0.39%)
Silver
16.685
+0.098
(+0.59%)


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

53938
Data from CryptoCompare
Recent Trending
50852
Okanagan Oldies
52157
Castanet Proud Member of RTNDA Canada
54235
Press Room
49335
53894